These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 55299)

  • 21. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
    Javadpour N; McIntire KR; Waldmann TA
    Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human B-HCG and AFP as biological markers in germinal testicular tumors].
    Huertas Mora RA; Larrodera López L; Gómez Matobella I; Cortes Funes H
    Rev Esp Oncol; 1984; 31(2):321-30. PubMed ID: 6085865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).
    Talerman A; Haije WG; Baggerman L
    Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
    Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
    Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
    Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
    Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
    Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
    Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
    Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
    Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
    Dunzendorfer U; Jurincic C
    Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors.
    Allen JC; Nisselbaum J; Epstein F; Rosen G; Schwartz MK
    J Neurosurg; 1979 Sep; 51(3):368-74. PubMed ID: 89191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
    Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
    Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
    [No Abstract]   [Full Text] [Related]  

  • 34. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocrinology of testicular germinal cell tumors.
    Aiginger P; Kolbe H; Kühböck J; Spona J; Geyer G
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):419-26. PubMed ID: 6167120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
    Jacobsen GK
    Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
    Sugiyama K; Arita K; Tominaga A; Hanaya R; Taniguchi E; Okamura T; Itoh Y; Yamasaki F; Kurisu K
    Brain Tumor Pathol; 2001; 18(2):115-22. PubMed ID: 11908867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.